Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effectiveness and Safety of the LC16m8 Mpox Vaccine in Individuals Aged One Year and Older in the Democratic Republic of Congo (DRC)

NCT07093489 is registered in ClinicalTrials.gov with International Vaccine Institute as lead sponsor.

NCT NCT07093489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07093489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effectiveness and Safety of the LC16m8 Mpox Vaccine in Individuals Aged One Year and Older in the Democratic Republic of Congo (DRC)
Lead sponsor
International Vaccine Institute
Phase
Observational
Overall status
Recruiting
Start date
December 3, 2025
Completion date
December 31, 2027
Enrollment
11,990 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mpox, mpox (monkeypox)